Los Angeles, California Clinical Trials

A listing of Los Angeles, California clinical trials actively recruiting patient volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 59 clinical trials
Treatment of Moderate to Severe Lateral Canthal Lines and Glabellar Lines Alone or in Combination

This study is designed to evaluate the safety and efficacy of a single dose of QM1114-DP for the treatment of moderate to severe LCL and moderate to severe GL, alone or in combination.

Skin Care & Laser Physicians of Beverly Hills
 (8.2 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +9 other locations
Testing the Addition of Radiotherapy to the Usual Treatment (Chemotherapy) for Patients With Esophageal and Gastric Cancer That Has Spread to a Limited Number of Other Places in the Body

This phase III trial studies how well the addition of radiotherapy to the usual treatment (chemotherapy) works compared to the usual treatment alone in treating patients with esophageal and gastric cancer that has spread to a limited number of other places in the body (oligometastatic disease). Radiotherapy uses high energy …

adenocarcinoma of esophagus
folfox regimen
celiac
immunodeficiency
sprue
Providence Saint Joseph Medical Center/Disney Family Cancer Center
 (9.3 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +254 other locations
Phase 2 Clinical Trial of Crizotinib for Children and Adults With Neurofibromatosis Type 2 and Progressive Vestibular Schwannomas

Subjects with Neurofibromatosis Type 2 (NF2) and progressive vestibular schwannoma (VS) will be treated with crizotinib administered orally. Crizotinib will be taken continuously until disease progression or unacceptable toxicity, in continuous treatment cycles of 28 days each, for a maximum of 12 cycles.

neurofibroma
cataract
schwartz
neutrophil count
multiple meningiomas
Univ of California @ Los Angeles (Site 325)
 (5.6 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +16 other locations
THE ALIGN-AR PIVOTAL TRIAL: JenaValve Pericardial TAVR Aortic Regurgitation Study

To collect information about treatment for symptomatic severe Aortic Regurgitation (AR), which affects the aortic valve in the heart. Aortic regurgitation is a condition where aortic valve in the heart does not close tightly and allows some blood to leak back into the heart chamber. Symptoms of aortic regurgitation may …

fatigue
shortness of breath
regurgitation
aortic valve replacement
Cedars Sinai Medical Center
 (7.5 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +9 other locations
Dupilumab Asthma Sleep Study

Primary Objective: To assess the effect of dupilumab on sleep Secondary Objectives: To evaluate the effect of dupilumab on additional patient reported sleep outcomes To evaluate the effect of dupilumab on objective sleep assessment To evaluate the effect of dupilumab on asthma symptoms To evaluate the effect of dupilumab on …

pulmonary function test
leukotriene receptor antagonist
corticosteroids
dupilumab
polysomnography
Investigational Site Number 8400009
 (7.5 away) Contact site
  • 0 views
  • 24 Nov, 2025
  • +10 other locations
None

Los Angeles Cancer Network
 (1.4 away) Contact site
  • 0 views
  • 19 May, 2025
  • +12 other locations
None

Los Angeles Cancer Network
 (1.4 away) Contact site
  • 0 views
  • 19 May, 2025
  • +13 other locations
PPMI 2.0 Clinical -Establishing a Deeply Phenotyped PD Cohort

The Parkinson Progression Marker Initiative 2.0 (PPMI 2.0) is a longitudinal, observational, multi-center natural history study to assess progression of clinical features, digital outcomes, and imaging, biologic and genetic markers of Parkinson's disease (PD) progression in study participants with manifest PD, prodromal PD, and healthy controls The overall goal of …

parkinson's disease
modafinil
datscan
alpha-synuclein
bradykinesia
Keck School of Medicine of USC
 (1.8 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +45 other locations
International Collaborative Gaucher Group (ICGG) Gaucher Disease Registry & Pregnancy Sub-registry

The ICGG Gaucher Registry is an ongoing, international multi-center, strictly observational program that tracks the routine clinical outcomes for patients with Gaucher disease, irrespective of treatment status. No experimental intervention is involved; patients in the Registry undergo clinical assessments and receive care as determined by the patient's treating physician. The …

imiglucerase
gaucher disease
eliglustat
deficiency
Investigational Site Number 840108
 (5.6 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +220 other locations
Mucopolysaccharidosis I (MPS I) Registry

The Mucopolysaccharidosis I (MPS I) Registry is an ongoing, observational database that tracks the outcomes of patients with MPS I. The data collected by the MPS I Registry will provide information to better characterize the natural history and progression of MPS I as well as the clinical responses of patients …

Investigational Site Number 840108
 (5.6 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +135 other locations